Richtech Robotics Launches Elevator Enabled Robot, Reducing Pharmacist Burnout

Amid a nationwide shortage of pharmacy staff, the company is addressing critical healthcare facility challenges by automating the safe and secure delivery of medications

Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics”), a Nevada company and a provider of AI-driven service robots, today announces the launch of its latest robot: Medbot, an elevator delivery robot designed to streamline pharmacy operations with uninterrupted, 24/7 medications delivery. With high operational accuracy, Medbot improves healthcare facility efficiency with a secure delivery, reducing operating costs and improving the overall patient experience. Medbot furthers Richtech Robotics’ mission of providing high-quality, stable robots to boost employee morale and improve customers’ bottom line.

“At Richtech Robotics, we’re passionate about pioneering solutions to mitigate workplace inefficiencies and build systems that address relevant industry concerns,” said Matt Casella, President of Richtech Robotics. “With a track record of success across the hospitality and service sectors, adapting our products to enhance conditions for the healthcare workforce and infrastructure was a natural progression for us. Finding a way to offload routine daily tasks for healthcare workers has been a pain point for many years, and we’re excited to launch an innovative solution to help hospitals gain a competitive edge.”

The launch of Medbot comes as the healthcare industry faces a concerning dearth of pharmacy staff. With Medbot, hospitals and clinics can automate medication deliveries with reliable, secure and uninterrupted service. Medbot can work up to 24 hours – and 10 hours continuously – making discreet deliveries to patients with high accuracy. In turn, this allows pharmacy technicians to stay stationed in the pharmacy for more important value-add tasks, rather than menial delivery tasks.

Additional product features include:

  • Elevator integration: Ensures reliable, smooth operation across complex spaces.
  • Four storage spaces: Holds up to 3.17 gallons each and can be opened one at a time if desired.
  • Smooth delivery: Works across versatile flooring, helping navigate dense crowds or cluttered spaces.
  • Large touchscreen display: Enables user-friendly, easy delivery scheduling management and real-time visibility.
  • Ultrasonic sensors (8) and cameras (2): Provides heightened obstacle detection and avoidance.
  • IoT enablement: Exchanges data with other devices and systems (e.g. smart doors).

To date, Medbot’s installations have a proven 100% delivery success rate. Medbots have been used in pharmacy to in-patient units and emergency departments, chemotherapy preparations to infusion centers, pharmacy-to-pharmacy/intra-pharmacy transport, and “meds-to-beds” discharge medications from outpatient pharmacy to the patient’s nurse.

“Amid rising operating expenses and a surge in patient numbers across the country, Medbot strives to empower healthcare facilities with superior care, despite staffing shortages. Our Medbot integration method is the only one on the market that has been proven to consistently work,” said Casella.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version